Skip to main content
HR 2064 116th Congress House Health Consumer affairs Government information and archives Health technology, devices, supplies Inflation and prices Prescription drugs

To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.

Introduced: April 3, 2019 Introduced by: Chu, Judy Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 21, 2019
Subcommittee Hearings Held.
Apr 4, 2019
Referred to the Subcommittee on Health.
Apr 3, 2019
Referred to the Subcommittee on Health.
Apr 3, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 3, 2019
Introduced in House
 Plain-English summary Congressional Research Service

This bill requires drug manufacturers to provide the Department of Health and Human Services with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.

What's happening now May 21, 2019

Subcommittee Hearings Held.

 Committees of jurisdiction 4